In collaboration with SIDP, the MAD-ID Annual Antimicrobial Stewardship Meeting is offering 6.25 contact hours toward recertification for Board Certified Infectious Diseases Pharmacists (BCIDP).
Please use the following link to purchase and enroll in the process for BCIDP recertification credit hours from the 2023 Annual MAD-ID Meeting: https://sidp.maplelms.com/course/info.php?id=30
Login with your SIDP member account email and password or sign up to become a Registered Resource User.
Fee to register for BCIDP credit: $100 (payable online when completing the BCIDP credit process)
Sessions for BCIDP credit are:
- Beta-lactam TDM, Practical Protocols to Make it Work (presented by Kate DeSear, PharmD and Veena Venugopalan, PharmD) – 5/10/2023
- Simple Strategies to Improve Outpatient Antimicrobial Use (presented by Mike Klepser, PharmD) – 5/11/2023
- Implementing Guidance in the Treatment of Gram-negative Infections (presented by Sam Aitken, PharmD, MPH) – 5/11/2023
- Diagnostic Stewardship Process and Practice (presented by Anthony Casapao, PharmD, MPH) – 5/11/2023
- A Clinician’s Guide to MICs and Breakpoints
-
- MIC, ECOFFs, and Breakpoints; What do I Need to Know as a Clinician? (presented by Kerry LaPlante, PharmD) – 5/12/2023
- Prevention Matters (SHEA)
-
- Immunization Stewardship (presented by Michael Hogue, PharmD) – 5/13/2023
- Microbiome Stewardship and Live Biological Products Role in Prevention of Infectious Diseases (presented by Sahil Khanna, MBBS,MS) – 5/13/2023
Participants must attend all BCIDP sessions and complete an online post-test and evaluation with SIDP to receive BCIDP recertification credit hours.
You must register for and attend MAD-ID to be eligible for BCIDP recertification credit. Register for MAD-ID here: https://mad-id.org/annualmeeting/registration/
Target Audience:
This activity was planned to meet the educational needs of board-certified infectious diseases pharmacists (BCIDPs).
Learning Objectives & Faculty:
Please refer to the MAD-ID Annual Meeting material for specific session and faculty information.
Accreditation:
BCIDP
The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certified infectious diseases pharmacist (BCIDP) credit. A BCIDP statement of credit will be issued online upon successful completion of a post-test and online evaluation. The post-test must be successfully completed in only one attempt. No partial credit will be given. BCIDP accreditation begins 5/10/2023 for this activity and is available for one year from this date.
Recertification Criteria for Infectious Diseases Pharmacy: BCIDP recertifying via continuing education are required to earn 100 hours of continuing education credit provided by the joint program offered by the Society of Infectious Diseases Pharmacists (SIDP), American College of Clinical Pharmacy (ACCP) and/or the American Society of Health-System Pharmacists (ASHP). Infectious Diseases Pharmacy Specialty Recertification Courses offered by any of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle. Candidates should note that there are expiration dates associated with earning BPS recertification credit. BPS will only award recertification credit for modules based on the completion and submission date of the post-test assessment. For example, a module completed and submitted on October 20 of a particular year will only be credited for that year, even if the due date of the post-test is in January of the following year. View all recertification criteria on the BPS website at https://www.bpsweb.org/recertification/recertification-by-continuing-education
Funding:
This activity is provided by SIDP. No external funding was received for this activity.
Disclosures:
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, SIDP asks all individuals involved in the development and presentation of CE activities to disclose all relevant financial relationships with ineligible companies. Faculty disclosure will be announced through MAD-ID.
Disclaimer:
Faculty members are asked to disclose when any unlabeled/investigational use of pharmaceuticals and devices is being discussed. This activity is intended for educational purposes and should not be used as a substitute for care or advice from a professional. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SIDP.
The planners and faculty of this continuing education activity have made all reasonable efforts to ensure the accuracy of the information presented in accordance with the latest available scientific knowledge at the time of publication. Healthcare professionals should verify all information and data with recommendations of other authorities before treating patients or employing any therapies described in this continuing education activity.
.gif){kind=logo}